Detalhe da pesquisa
1.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood
; 139(19): 2931-2941, 2022 05 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35007321
2.
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.
Nature
; 559(7712): 125-129, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29950729
3.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36251406
4.
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.
Br J Haematol
; 192(6): 1054-1063, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33618432
5.
Oral idasanutlin in patients with polycythemia vera.
Blood
; 134(6): 525-533, 2019 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31167802
6.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31515250
7.
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.
Biol Blood Marrow Transplant
; 25(2): 256-264, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30205231
8.
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.
Blood
; 130(6): 732-741, 2017 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28588019
9.
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.
Blood
; 122(7): 1256-65, 2013 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23699601
10.
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.
Blood Adv
; 7(17): 5000-5013, 2023 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37142255
11.
A Phase Ib Trial of AVID200, a TGFß 1/3 Trap, in Patients with Myelofibrosis.
Clin Cancer Res
; 29(18): 3622-3632, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37439808
12.
De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features.
Leuk Res
; 117: 106857, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35598475
13.
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.
JCI Insight
; 7(8)2022 04 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35259128
14.
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.
Clin Cancer Res
; 28(8): 1614-1627, 2022 04 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35078859
15.
LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms.
Cancer Discov
; 11(6): 1398-1410, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33579786
16.
Evaluating Clonal Hematopoiesis in Tumor-Infiltrating Leukocytes in Breast Cancer and Secondary Hematologic Malignancies.
J Natl Cancer Inst
; 112(1): 107-110, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31504684
17.
Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin.
Blood Adv
; 4(22): 5735-5744, 2020 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33216890
18.
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase.
Blood Adv
; 4(20): 5246-5256, 2020 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33104796
19.
Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Nat Genet
; 52(11): 1219-1226, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33106634
20.
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial.
Clin Cancer Res
; 25(16): 4898-4906, 2019 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31061068